Six peptides were reviewed for compounding inclusion in July 2026. We're preparing to prescribe the ones that passed — the moment U.S. compounding pharmacies can legally make them. Provider-supervised, lot-tested, shipped to your door.
Each one below was reviewed in July 2026 and recommended for inclusion on the compounding bulk-substances list. Every page states plainly how strong the evidence is.
The body-protection compound. Studied for gut lining healing, tendon and ligament repair, and lowering inflammatory signaling.
A three-amino-acid fragment of α-MSH. Studied topically and systemically for inflammatory skin and gut conditions.
A synthetic form of thymosin beta-4. Studied for cell migration and tissue repair after injury.
A mitochondrial-derived peptide studied for metabolic regulation, insulin sensitivity, and bone density.
A four-amino-acid peptide studied for pineal regulation and sleep architecture, with claims about aging that outrun the data.
An ACTH-derived peptide used clinically in Russia for stroke recovery and studied for cognition and neuroprotection.
Emideltide (DSIP) was reviewed the same week for opioid withdrawal, chronic insomnia, and narcolepsy. The advisory vote came back 6–7 against inclusion, so we won't be offering it. We're listing that here rather than quietly leaving it out.
If a clinic offers you DSIP, ask where they're getting it. There is no lawful U.S. compounding path for it right now.
The same process as every other treatment we offer. No mystery vials, no "research use only" loopholes.
Tell us which peptide you're interested in. We'll email you the week it becomes available — nothing before that.
A licensed provider reviews your history, medications, and labs, then decides whether a peptide is appropriate — or tells you it isn't.
Your prescription is filled by a licensed U.S. compounding pharmacy, with potency, sterility, and endotoxin testing tied to your lot.
Your provider owns the dose and the bloodwork. If you're already on TRT with us, it all stays in one chart.
Nearly every peptide sold in the U.S. today arrives from unregulated overseas labs, labeled "for research use only" so the seller never has to answer for what's inside. This is the whole reason we're waiting instead of drop-shipping.
Plain-language reading and video from our medical team, plus the outside sources we think are worth your time.
Our providers walk through all six peptides, the July advisory votes, and the questions to ask any clinic selling them today.
Six peptides, one page, no hype. What each is studied for, how strong the evidence is, and who it isn't for.
Third-party assay results published in full — potency, sterility, endotoxin, and what the labels claimed instead.
Still unsure? Message our team — you don't need to be a patient to ask.
Ask a QuestionWe don't have a date, and we won't invent one. Five of these six were recommended for inclusion on the compounding bulk-substances list in July 2026, which is the step that lets U.S. compounding pharmacies legally prepare them. Once a pharmacy we trust can produce and test them, we'll email the waitlist that week.
No. Nothing on this page is for sale. If a clinic is selling you peptides today, ask them which licensed U.S. pharmacy compounded it and to show you the lot-specific sterility and potency testing. Most cannot.
Depends entirely on what you're trying to fix, and that's a conversation with a provider, not a shopping decision. BPC-157 has the deepest record for soft-tissue and gut repair, which is why it's featured — but your history and labs decide, and sometimes the answer is none of them.
There's no known interaction, and many of the men asking us about peptides are already on testosterone. Because your provider manages both, dose changes and bloodwork stay in one place instead of being split across two clinics.
Possession isn't a criminal matter for individuals, but none of these are approved drugs, and selling them for human use is not lawful. That's why the gray market labels everything "research use only." A prescription from a licensed provider, filled by a licensed compounding pharmacy, is the legitimate path.
Then several of these are off the table. BPC-157 and TB-500 are on the WADA prohibited list, and our providers will not prescribe them to a tested athlete. We'd rather lose the sale than cost you a season.
We haven't set pricing because we haven't set a supplier. When we do, it will be published the same way our TRT pricing is: one number, per month, no bundling tricks.
Join the waitlist and we'll email you the week peptides are available. Already a patient? Bring it up at your next visit — or book a consult now to get your intake done early.
By joining, you opt in to launch and marketing email about Peptides from AlphaMD. You can unsubscribe at any time.
No insurance needed · Cancel anytime · 100% confidential
The peptides described on this page are not FDA-approved drugs and are not currently available for sale or prescription through AlphaMD. Nothing on this page is an offer to sell, and nothing here is medical advice. Statements about potential benefits describe published preclinical and early clinical research and are not claims about outcomes for any individual. Peptide therapy, if and when offered, will require a consultation with a licensed medical professional, a completed medical intake, and appropriate laboratory testing; it is not appropriate for everyone. Several of these peptides are prohibited by the World Anti-Doping Agency.
Medical services are provided by independent, licensed providers through AlphaMD's affiliated professional practices. AlphaMD provides administrative and technology services and does not practice medicine.